115370 Results

People

  1. Ladanyi
    Ladanyi
  2. Motzer
    Motzer
  3. Reuter
    Reuter
  4. Scher
    Scher
  5. Brennan
    Brennan
  6. Giralt
    Giralt
  7. Gonen
    Gonen
  8. Perales
    Perales
  9. Hudis
    Hudis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (39030)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)
  7. Center for Hematologic Malignancies (13261)
  8. Hematologic Malignancies, Division of (13086)
  9. Sloan Kettering Institute Postdocs (12935)
  10. Department of Pathology and Laboratory Medicine (12608)
Formats
  1. Journal Article (66747)
  2. Meeting Abstract (33620)
  3. Book Section (5027)
  4. Review (3743)
  5. Editorial (2162)
  6. Conference Paper (1525)
  7. Correspondence (661)
  8. Guidelines (660)
  9. Research Letter (548)
  10. Miscellaneous (339)
  11. Book Whole (338)
Groups
  1. Department of Medicine (39030)
  2. GSK Faculty (22466)
  3. Solid Tumor Oncology Division (22055)
  4. Surgery (21246)
  5. Sloan Kettering Institute Faculty (16085)
  6. Survivorship Research (15761)

More Groups

People
  1. Marc Ladanyi (1326)
  2. Robert Motzer (1243)
  3. Victor Reuter (1228)
  4. Howard Scher (1130)
  5. Murray Brennan (1059)
  6. Sergio Giralt (1049)

More People

Years
  1. 2025 (1982)
  2. 2024 (5377)
  3. 2023 (5804)
  4. 2022 (6168)
  5. 2021 (5712)
  6. 2020 (5598)

More Years

Publications
  1. Journal of Clinical Oncology (8590)
  2. Blood (4950)
  3. Cancer Research (2701)
  4. International Journal of Radiation Oncology, Biology, Physics (2610)
  5. Laboratory Investigation (1879)
  6. Modern Pathology (1812)

More Publications

Publishers
  1. Elsevier Inc. (13855)
  2. American Society of Clinical Oncology (9157)
  3. Springer (7152)
  4. Nature Publishing Group (6367)
  5. American Association for Cancer Research (6002)
  6. Elsevier Science, Inc. (5503)

More Publishers

Results (115370)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: Validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all-trans retinoic acid
    Research Letter

    Silva, W. F.; Kim, H. T.; Undurraga, M. S.; Navarro-Cabrera, J. R.; Salinas, V.; Muxi, P.; Melo, R. A. M.; Gloria, A. B. F.; Pagnano, K. B. B.; Nunes, E. C.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: A real-world observational study in the United States
    Research Letter

    Hultcrantz, M.; Kleinman, D.; Vij, R.; Escalante, F.; Delforge, M.; Kotowsky, N.; Bitetti, J.; Boytsov, N.; Camadoo-O’Byrne, L.; Happ, L. P.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Targeting of PIM kinases shows single agent efficacy and synergizes with BCL2 inhibitors in diffuse large B cell lymphoma of the ABC subtype
    Journal Article

    Tarantelli, C.; Kayali, O.; Civanelli, E.; Cascione, L.; Mensah, A. A.; Folloni, C.; Arribas, A. J.; Rinaldi, A.; Cmiljanovic, V.; Mondello, P.; more...
    Hematological Oncology (2025)

    Fulltext@MSK | Save
  • Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: A real-world analysis from 21 US centers
    Journal Article

    Zelikson, V.; Gurumurthi, A.; Sawalha, Y.; Annunzio, K.; Saha, A.; Dong, N.; Qualls, D.; Amoozgar, B.; Kahl, B.; Baird, J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Goldman, A.; Tomas, A. A.; Fein, J. A.; Slingerland, J. B.; Parascondola, A.; Lin, R. J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate
    Journal Article

    Johannet, P.; Flint, M.; Chui, M. H.; Konner, J.; Friedman, C.; Green, A. K.; Guo, R.; Hensley, M. L.; Kyi, C.; Liu, Y.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Anaplastic carcinoma of the ovary: A single-institution experience and molecular analysis
    Journal Article

    Sullivan, M. W.; Chui, M. H.; Selenica, P.; Long Roche, K.; Sonoda, Y.; Grisham, R. N.; Kyi, C.; Momeni-Boroujeni, A.; Abu-Rustum, N. R.; Weigelt, B.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial
    Journal Article

    Leath, C. A. 3rd; Deng, W.; Mell, L. K.; Richardson, D. L.; Walker, J. L.; Holman, L. L.; Lea, J. S.; Amarnath, S. R.; Santos-Reyes, L. J.; Arend, R. C.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • The genomic landscape of distant metastatic endometrial cancer
    Journal Article

    Zammarrelli, W. A. 3rd; Nandakumar, S.; Kertowidjojo, E.; Nguyen, B.; Moukarzel, L. A.; Da Cruz Paula, A.; Rios-Doria, E. V.; Smith, S. A.; Momeni-Boroujeni, A.; Makker, V.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study
    Journal Article

    Bae-Jump, V. L.; Sill, M. W.; Gehrig, P. A.; Merker, J. D.; Corcoran, D. L.; Pfefferle, A. D.; Hayward, M. C.; Walker, J. L.; Hagemann, A. R.; Waggoner, S. E.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save